McNeil Consumer Products traded its over-the-counter Nasalcrom allergy spray, Micatin anti-fungal products and Pediacare children's cough/cold brands to Pharmacia & Upjohn for worldwide rights to the Motrin pain reliever brand as well as Mycitracin ointment. McNeil began marketing Children's Motrin OTC in 1995. Saatchi & Saatchi's Healthcare Connection won the $41 million Nasalcrom account from DDB
Needham in January. W.B. Doner
& Co., Southfield, Mich., handles Motrin, which fell to $16.6 million in media support last year. McCann-Erickson, New York, handles Micatin's $9.5 million account, while Mycitracin was unsupported. McNeil and Pharmacia said future agency assignments are undetermined.
Copyright June 1997, Crain Communications Inc.